A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer

NCT00623805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Bevacizumab
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Hoffmann-La Roche